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Abstract
In recent years, infectious diseases, specifically those that are caused by patho-
gens, have seen a dramatic proliferation due to resistance to multiple antibiotics, 
opening the colony by opportunistic pathogens. Nanotechnology and tissue 
engineering have been applied in the development of new antimicrobial therapies, 
capable of fighting opportunistic infections. In the medical field, research on 
antimicrobial properties of metal oxide nanoparticles have emerged to find new 
antimicrobial agents as an alternative against resistant bacteria. The metal oxides, 
particularly those formed by transition metals are compounds with electronic prop-
erties, and most magnetic phenomena involve this type of oxides. Nanoparticles-
based metal oxide properties such as shape, size, roughness, zeta potential and their 
large surface area, make oxides ideal candidates to interact with bacteria and able to 
have an antimicrobial effectiveness. The aim of this chapter is to offer an updated 
panorama about the relationships between the use of metal oxide nanoparticles in 
the medical field, with an emphasis on their role as antimicrobial agents and the 
properties that influence their antimicrobial response. In addition, the mechanism 
of nano-antimicrobial action is described and the importance of using in vitro test 
methods, adopted by leading international regulatory agencies, that can be used to 
determine the antimicrobial activity of the metal oxide nanoparticles.
Keywords: nanoparticles, metal oxide, antimicrobial, in vitro, methods,  
mechanism of action, nano-antimicrobial
1. Introduction
Infectious diseases are one of the main causes of morbidity and mortality in the 
world, so there is the need for research on antimicrobial agents. According to the World 
Health Organization (WHO), resistance to antimicrobials endangers the effectiveness 
of treatments for an increasing series of infections by bacteria and fungi [1]. In addi-
tion, it poses a growing threat to global public health and requires action by all sectors 
of government, industry, healthcare professions and society. The success of surgery and 
medical therapy will increasingly be compromised in the absence of effective antibiot-
ics. On the other hand, the dissemination of multidrug-resistant infections will increase 
the need for laboratory tests and the use of more expensive drugs, thus increasing the 
cost of healthcare.
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In the science of materials, there is an interest in the development of new anti-
microbial therapies, capable of fighting opportunistic infections. For this reason, 
it is important as a first step, to take into account the different laboratory methods 
that can be used to evaluate antimicrobial activity in vitro. The aim of this methods 
is to detect possible drug resistance in common pathogens [2], but also which are 
the most appropriate assays to be used in new agents and materials what that have a 
potential therapy application.
Nanotechnology and tissue engineering are potential applications for the 
reported antimicrobial properties of nanoparticles (NPs). Some of the potential 
advantages of NPs, to fight against microorganisms, are that they do not generate 
resistance and are a safe potential antimicrobial alternative for clinical use [3–5].
However, the research in this area is needed to understand the mechanism of 
action of NPs and how to design better therapies. In recent years, nanoparticles 
have been incorporated into the medical field as an alternative to new antimicrobial 
agents, especially oxides based in silver (Ag), copper (Cu), and titanium (Ti) [6]. 
On the other hand, findings have raised concerns about their possible toxic effects 
in humans, triggering an interest to investigate more about the nanotoxicology and 
the search for new antibacterial nanomaterials with nontoxic properties for human 
being [7–9].
The antibacterial activity of the NPs depends of the size and shape; so it requires 
active research of nanometer-scale materials. Recently, basic and applied research 
has been done on various metal oxides with different shapes and sizes has carried 
out for their application in a broad scale of areas such as catalysis, in semiconduc-
tors, sensors, controlled release of drugs and as antimicrobial agents.
The physical and chemical properties of metal oxide NPs allow their interaction 
with biological systems, which has become of vital importance due to the increasing 
resistance of bacteria. Within these properties, there are shape, size, roughness, 
zeta potential and coatings, among others [5, 10]. The antimicrobial activity pre-
sented by the NPs of metal oxides could have a mainly therapeutic application, but 
it can also be extended to the food industry, to water purification and to the textile 
industry.
The present chapter will be focused on recent reports that explore the relation-
ships between the use of NPs in the medical field, with an emphasis on their role as 
antimicrobial agents and the physicochemical properties of metal oxide NPs that 
influence their antimicrobial response.
Additionally, findings will address antimicrobial activity of novel metal oxides 
NPs based in zinc, manganese, iron and magnesium. Also, we will discuss diverse 
methods for the assessment of antimicrobial activity that can have uses for metal 
oxide NPs and which complies with quality according to official standards to evalu-
ate antimicrobial agents and materials.
2. Antimicrobial applications of nanoparticles
The rapid emergence of resistant pathogens is occurring worldwide, endanger-
ing the efficacy of antibiotics, which have pushed medicine to evolve and save 
millions of lives. Resistance of the pathogens has been attributed to the overuse and 
misuse of antibiotic medications, as well as the lack of new strategies for antibacte-
rial development to address the challenge [11, 12]. This challenge suggests that the 
focus of research on resistance pathogens must be turned to the discovery of novel 
strategies to fight the pathogen infections. One of the new areas that is emerging in 
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response for this challenging menace is the use of nanotechnology, mainly by the 
identification of how the manipulation of materials for the synthesis of NPs could 
be utilized for the therapeutic management of pathogen infections [13].
Research on the synthesis, characterization and application of NPs as an antimi-
crobial system is a new area of interest in the biomedical and healthcare fields due 
to the possible enhancement of nanoparticles within their physiochemical behavior 
against drug-resistant pathogens due to size effect, doping effect, could be cost-
effective and they are quite stable enough for long-term storage with a prolonged 
shelf-life. Moreover, the NPs could be subjected to sterilization by methods of high 
temperature, gamma irradiation or plasma treatment without losing its properties 
or inactivation [14].
In reference to the biomedical field, the benefits of nanotechnology have been 
quite substantial, for example, there are devices with antimicrobial nanoproperties 
such as heart valves, catheters, and dental implants [10]. The type of nanolayers 
covering these kind of devices can delay or inhibits the adhesion and growth of 
bacteria such as Streptococcus mutans, Staphylococcus epidermis, and Escherichia 
coli. Other implantable material is bone cement based polymethyl methacrylate 
(PMMA) with Ag nanoparticles that have demonstrated significant reduction in the 
number of arthroplasty surgery-related infections, including methicillin-resistant 
Staphylococcus aureus (MRSA), S. aureus, S. epidermidis, and Acinetobacter baumannii  
infections [10, 15].
The application of nanoparticles used to fight against pathogens consist mainly 
of metals and metal oxides of zinc, silver, copper or titanium, because they 
naturally exhibit microbiocidal or microbiostatic actions and have demonstrated 
bactericidal activity against both Gram-positive and Gram-negative bacteria. The 
bactericidal application of metal NPs is based on the mechanism that affect the 
respiration system by photocatalytic production of reactive oxygen species (ROS) 
that damage cellular and viral components that ultimately leads to bacterial death, 
compromising the bacterial cell wall/membrane, inhibition of enzyme activity and 
DNA synthesis, interruption of energy transduction and the most important the 
pathogens do not develop resistance to metal NPs [16, 17].
Besides as metal nanoparticles could target the bacterial cell wall; there is an oppor-
tunity to dope the nanoparticles with relevant antibiotics to enhance their antibacterial 
action through synergy offering multiple advantages as controllable with sustained 
and relatively uniform distribution release in the target tissue, improving the solubil-
ity, minimized side effects and enhanced cellular internalization [14, 18, 19].
3. Metal oxide nanoparticles as antimicrobial agents
The resistance of microorganisms to the action of antimicrobial agents, espe-
cially antibiotics, is a serious public health problem, which has been a reason for the 
search and development of new antimicrobials through nanotechnology.
The manipulation on a nanoscale of metal oxide has provided new research 
in the pharmaceutical area due to the antimicrobial properties of these oxides, 
according to data revealed in in vitro studies [20, 21]. In this sense, the metal 
oxide NPs between 1 and 100 nm with different shapes allow their physical and 
chemical properties could become in some promise antimicrobial agents against 
infectious diseases for the recent findings about their interaction which has 
become of vital importance due to the increasing of infection diseases by bacterial 
resistance [22, 23].
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3.1 Mechanisms of antimicrobial activity
There are findings about the potential mechanisms of action, where it attempts 
to explain the bactericidal effect of metal oxide NPs [10, 24–27]. Some of these 
include the action of reactive oxygen species (ROS), the electrostatic interaction, 
accumulation, ions delivered and contact by itself of NPs, that induce a several 
effects from outside and into the bacteria, and that it will be described below 
(Figure 1).
3.1.1 Formation of reactive oxygen species (ROS)
They are a group of reactive molecules produced in some metabolic processes 
in which oxygen participates: the superoxide anion O2− which is a powerful oxi-
dizing agent very reactive with water. Hydrogen peroxide H2O2 and the hydroxyl 
radical (•OH) which is the most reactive, since accepting one more electron, gives 
rise to a water molecule. Metal oxides NPs are capable of producing different reac-
tive oxygen species may participate in different types of reactions in which they 
can undergo oxidation or reduction processes. ROS produce disruption of DNA, 
damage by oxidation of polyunsaturated fatty acids and amino acids. The altera-
tion of the balance in the mechanisms of production and elimination of ROS, in 
favor of production, originates the state of oxidative stress in the bacteria cell. In 
the case of O2 and H2O2 cause less acute stress reactions and can be neutralized by 
endogenous antioxidants, such as superoxide and catalase enzymes, while OH− 
and O2 can lead to acute microbial death.
Figure 1. 
Mechanisms of action of the bactericidal effect from metal oxide nanoparticles.
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3.1.2  Damage to the wall-cell membrane due to electrostatic interaction and 
accumulation
The electronegative groups of the polysaccharides in the bacterial membrane 
have an attraction sites by metal cations. The difference in charge between bacte-
rial membranes and the NPs of metal oxides leads to electrostatic attraction and 
thus accumulates on the bacteria surface, altering the structure and permeability 
of the cell membrane. Gram-negative bacteria have a higher negative charge than 
Gram-positive bacteria and therefore the electrostatic interaction will be stronger 
in Gram-negative strains. The pores of the membranes are in the order of nano-
meters, therefore the smaller the particle size and the greater the surface area, the 
greater the efficiency of the metal oxide nanoparticles. In the same way, the cations 
extracted from the NPs of the metal oxides and their accumulation in the cell wall, 
create pits in it, leading to a change in permeability due to the sustained release 
of lipopolysaccharides, membrane proteins and intracellular factors. In addition, 
this mechanism has been linked to the interruption of the replication of adenosine 
triphosphate (ATP) and the deoxyribonucleic acid (DNA) of the bacterium, leading 
to its death. One study indicates that the action of NPs depends on the components 
and structure of the bacterial cell. The unique components of Gram-negative 
bacteria, such as LPS, can prevent the adhesion of metal oxides NPs to the bar-
rier of bacterial cells and regulate the flow of ions in and out of the bacterial cell 
membrane.
3.1.3 Loss of homeostasis by metal ions
The balance of metallic elements is essential for microbial survival, since it 
regulates metabolic functions by helping coenzymes, cofactors and catalysts. 
When the bacteria have an excess of metals or metal ions, there will be a disorder 
in the metabolic functions. Metal ions bind with DNA and alter the helical nature 
by cross-linking between and within the DNA strands. The metal ions neutralize 
the charges in LPS and increase the permeabilization of the outer membrane. The 
ions of metal oxides might also cause the decomposition of bacterial cells due to 
the diffusion of metal ions by generating large amounts of hydroxyl radicals and 
diffusion in bacterial cells. Other studies indicate that NPs of metal oxides slowly 
release metal ions through adsorption, dissolution and hydrolysis; they are toxic 
and abrasive to bacteria and, therefore, lyse the cells.
3.1.4 Dysfunction of proteins and enzymes
Protein dysfunction is another mode of antibacterial activity exhibited by NPs 
of metal oxides. The metal ions catalyze the oxidation of the side chains of amino 
acids resulting in carbonyls bound to proteins. The carboxylation levels within the 
protein molecule serve as a marker for the oxidative damage of the protein. This 
carboxylation of proteins will lead to the loss of catalytic activity in the case of 
enzymes, which finally triggers the degradation of proteins.
3.1.5 Inhibition of the transduction signal
Electrical properties of metal oxide NPs interact with nucleic acids inducing 
suppress of cell division by altering processes of replication of the chromosomal 
DNA and the plasmid in microorganism. It is known that signal transduction in 
bacteria is affected by NPs of metal oxide. Phosphotyrosine is an essential com-
ponent of mechanism of signal transduction in bacteria. NPs dephosphorylate 
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the phosphotyrosine residues, which inhibits signal transduction and, ultimately, 
obstructs growth of bacteria.
3.2 Nanoparticle characteristics and their influence of antimicrobial activity
Other factors of the antimicrobial activity, has been sought to analyze what 
characteristics influence the microbial response to the action of the metal oxide 
nanoparticles. It is known of existing reports concerning the chemical-physics 
properties from the metal oxide nanoparticles, but taking into consideration factors 
like the shape, size, roughness, zeta potential and coatings, etc., that influence 
the resultant antimicrobial effectiveness [5, 10]. These results could have a mainly 
therapeutic application in medicine, but it can also be extended to the food indus-
try, to water purification and to the textile industry [28].
3.2.1 Size and shape
Several reports mention that the size and shape are the most important factors 
to the antimicrobial activity [23, 29–31]. With respect to size there are findings 
where this is a crucial factor to damage the bacterial systems for many reasons. The 
sizes as <30 nm are factors that allows the accumulation and penetration into the 
bacteria causing damage and consequently leading to bacteria death (<10 nm) [23]. 
The same authors point out that metal oxide nanoparticles with a size greater than 
10 nm promotes the permeability when coming into contact with bacteria [23]. 
In relation with this, the specific surface area by the nanoparticle size affects the 
surface to mass ratio affecting on surface reactivity. For this reason, they can also 
have influence in many direct mechanisms of toxicity against the bacteria and the 
subsequent loss of viability (Figure 1).
With respect to shape, it is by knowing that depending on the synthesis method, 
it will obtain the form of the nanoparticle [32]. Numerous studies shown vari-
ous forms obtained like spherical, rod-shaped, truncated triangular, nanotubes, 
nanorods, nanowires, nanosphere, nanoneedles, nanorings and nanocubic [23, 33, 34]. 
Evidence reports that needle-shaped metal oxides nanoparticles present higher 
antibacterial activity than cubic shaped, based on the optical and fluorescence 
intensity [30].
3.2.2 Surface and zeta potential
The relation between the surface nanoparticle/nanomaterial and bacterial 
adhesion has not been fully studied and there are few reports about it. Some studies 
report that the adsorption of bacterial proteins is promoting by the surface area-
to-mass ratio carry out the reduction in bacterial adhesion [35–37]. Surface nano-
materials have high degree of roughness, therefore bacteria cell membranes cannot 
adhere to the surface nanomaterial; so the bacteria adhesion is reduced [10, 38, 39].
The surface charge or zeta potential could be another property of the 
nanoparticle related with bacteria adhesion since it is important to mention that 
if the surfaces with negative charge are capable to decrease the interaction with 
bacteria charged negatively, the surface of nanomaterial with negative charge 
could obtain the same effect, compromising bacterial adhesion [10, 23, 40]. 
On the other hand, the electrostatic attraction occurs when the nanoparticles 
are positively charged promoting the accumulation in bacterial cell membrane, 
which is negatively charged and then they penetrate inside the bacteria trigger-
ing other mechanisms [23] (Figure 1).
7
In vitro Antimicrobial Activity Evaluation of Metal Oxide Nanoparticles
DOI: http://dx.doi.org/10.5772/intechopen.84369
3.2.3 Chemical doping
Nanoparticle chemical doping is a modification and functionalization around 
the surface of nanoparticles to regulate and control the interaction with bacteria 
and enhance their antimicrobial effect. Reports have shown this method as a factor 
to improve the presence of surface oxygen atoms that promote the production 
of reactive oxygen species (ROS) [23]. Similarly, the chemical functionalization 
increase of the surface-area-to-volume ratio results in increasing the antimicrobial 
potential activity [38]. Also, this procedure has prevented the agglomeration and 
the solubility in different solutions [10].
3.3 Metal oxide nanoparticles
The transition metal oxides (TMO) are compounds with unique electronic 
properties, most magnetic phenomena involve this type of oxides. The nanostruc-
tures formed by TMO, due to their dimensions of a few nanometers and their large 
surface area, are ideal candidates to interact with bacteria. It is known that NPs 
of the silver are excellent antimicrobial agents and they are the more studied and 
reported. However, in vitro and in vivo studies indicate that nanoparticles based 
Ag, Cu and Ti are toxic to mammalian cells derived from the skin, liver, lung, brain, 
vascular system, and also gives rise to a distribution in other organs, where are in 
accumulations [8, 9].
Therefore, is important that the different metal oxides nanoparticles will be 
studied and guarantee it clinical use. In particular, there are reports concerning to 
zinc oxide (ZnO), trimanganese tetroxide (Mn3O4), magnetite (Fe3O4) and magne-
sium oxide (MgO) nanoparticles that have antimicrobial properties.
3.3.1 ZnO nanoparticles
Zinc oxide is a compound with excellent antimicrobial properties. It is an n-type 
semiconductor with a band gap of 3.3 eV. ZnO NPs can adopt a wide variety of 
morphologies such as; rings, propellers, belts, wires, among others [41, 42]. The 
antimicrobial activity of ZnO NPs happens by different mechanisms, one of these is 
the ROS generation [43] inside the cell. It has been proposed that ZnO NPs can act 
to generate cell death, or the release of Zn2+ ions, whose excess generates an altera-
tion of cellular metabolism. Some species reported as susceptible to ZnO nanopar-
ticles are; S aureus, S. epidermidis, Streptococcus pyogenes, Enterococcus faecalis [44], 
Bacillus subtilis, Escherichia coli and Klebsiella pneumonia [41]. These bacteria can 
generate intra-hospital infections causing serious infectious diseases and some 
strains are found in water or food, so ZnO NPs can have a possible application in 
these areas.
3.3.2 Mn3O4 nanoparticles
The trimanganese tetroxide, Mn3O4, is a mixed oxide of manganese (Mn (II) 
Mn (III)2O4) is a normal spinel and crystallizes in cubic form. It occurs in nature 
as the hausmannite mineral. The antimicrobials properties of Mn3O4 NPs have 
been little studied. Has been reported an effect of these diseases against strains 
of Vibrio cholerae, Shigella sp., Salmonella sp., and E. coli [45]. The effect of the 
NPs of Mn3O4 against has been evaluated against E. coli and S. aureus through 
microdilution assays [46]. The results of the minimum inhibitory concentra-
tion (MICs) indicated that the bacteria E. coli was more sensitive to the action 
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of the NPs of Mn3O4. It was observed that the inhibitory effect proportionally 
increases to the concentration of Mn3O4 NPs, which could divide the different 
characteristics of the surfaces of the bacterial cells and their interaction with the 
NPs, therefore the mechanism of action could be focused on the bacterial wall 
membrane.
3.3.3 Fe2O3 nanoparticles
Iron oxide (III) is a very stable oxide, it crystallizes in hexagonal form and is 
found in nature as the mineral hematite α-Fe2O3. The nanostructures of this oxide 
take different forms as they are nanowires, nanotubes, nanospheres, etc. [47]. 
Although its synthesis has been widely studied, its possible antibacterial effect not. 
The Fe2O3 NPs bactericidal effect against E. coli and S. aureus has been reported, 
where an increase of this effect is observed, as the concentration of iron oxide 
NPs increases [48]. A bactericidal effect has also been seen on P. aeruginosa with a 
minimum inhibitory concentration of 0.06 mg/L [49]. Another study reports on 
the bactericidal activity of nanostructured hematite against a variety of Gram-
positive and Gram-negative bacteria; P. aeruginosa, S. aureus, K. pneumoniae, 
Lysinibacillus sphaericus and Bacillus safensis [50]; proposing some mechanisms 
of action depending on the activity observed in each stage of the growth of the 
bacteria in question. A bactericidal effect of NPs of Fe2O3 against S. epidermidis has 
even been determined [51].
From its properties, its possible application in the remediation of the environ-
ment and water, as well as in the biomedical area, has been proposed, due to the 
different studies of cytotoxicity that have been carried out [47].
3.3.4 MgO nanoparticles
Magnesium oxide is in nature as the mineral periclase [52]. The antibacterial 
activity of MgO against Gram-positive and Gram-negative bacteria has been 
reported. It has been proposed that MgO NPs can damage the cell membrane 
causing the loss of intracellular contents and causing the death of bacterial cells 
[53]. The generation of reactive oxygen species has been attributed to the surface 
alkalinity of the MgO NPs [54]. The antibacterial activity of NPs of MgO against 
Gram-negative bacteria has been evaluated; E. coli and P. aeruginosa (500 and 
1000 μg/mL) and in a Gram-positive bacterium; S. aureus (1000 μg/mL) [55]. The 
MgO NPs potentiated lipid peroxidation induced by ultrasound in the liposomal 
membrane. In this case the mechanism of action could be associated to the pres-
ence of defects, or to the lack of oxygen on the surface of the NP, leading to lipid 
peroxidation and the generation of reactive oxygen species [55]. The antibacterial 
effect and mechanism of action of NPs of MgO against strains of Campylobacter 
jejuni, E. coli and Salmonella enteritidis has been studied [56]. In this case, it was 
observed that the permeability of the bacteria’s membrane, after exposure to the 
MgO NPs, was compromised, finding the presence of hydrogen peroxide that 
would subsequently cause cell death. Studies of P. aeruginosa and S. aureus versus 
MgO NPs showed a greater zone of inhibition in S. aureus than in P. aeruginosa 
[56]. Based on previous work, the authors note that the bactericidal action of MgO 
NPs may be due to the binding of surface oxygen to bacteria. As the surface area of  
the particles increases, the concentration of oxygen ions on the surface increases, 
which results in a more effective destruction of the cytoplasmic membrane and the 
cell wall of the bacteria.
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4.  In vitro methods for antimicrobial evaluation of nanoparticles based 
metal oxide
Bacteria exposed to antimicrobials are under selective pressure to evolve 
and adapt, this natural process leads to antimicrobial resistance. Human kind 
is facing the growing threat of rapid evolution and dissemination of bacteria 
resistant to multiple antibiotics. There is, therefore, an urgent need to develop 
new antimicrobials [57, 58].
Antimicrobial agents include disinfectants, antiseptics, and antibiotics. New 
agents must be exhaustively tested for efficacy and safety. Evidence-based selection 
of the microorganisms and the evaluation system is of paramount importance for 
adequate interpretation of the test results, and for extrapolating from in vitro to 
real-life scenarios.
The use of nanoparticles especially based in metal oxides emerge as new antimi-
crobial agents, therefore it is necessary to test the efficacy of nano-antimicrobials 
against representative bacterial species. One known limitation of the testing 
systems currently in use, is that formulations are often challenged in vitro with one 
microbial species at the time, and rarely against multi-species biofilms.
4.1 Regulatory testing
Regulatory agencies require adherence to well established evaluation systems. 
Regulatory tests applicable to disinfectants, antiseptics or therapeutic antimi-
crobials vary greatly; and could include to nanoparticles with potential use as 
antimicrobials.
4.1.1 Disinfectants
When evaluating chemical disinfectants, bacterial endospores are considered 
the microbial life-form hardest to kill, followed in descendent order by mycobacte-
ria, bacteria in vegetative form, and viruses.
In the United States, the Food and Drug Administration (FDA) regulates 
chemical sterilants and high level disinfectants (HLD) that are used to reprocess 
medical instruments [59]. The AOAC International sporicidal and tuberculocidal 
tests are the accepted methods for evaluation. For a liquid chemical sterilant, the 
FDA standard tolerates no failures in the AOAC sporicidal test 966.04, and accepts 
no survivors in simulated-use testing with a challenge inoculum of six logs of 
spores. The FDA defines HLD as sterilants used under the same contact conditions 
but for only the contact time needed to reduce Mycobacterium bovis in 6 log10 in the 
tuberculocidal test 965.12 [60]. Moreover, to be approved, the disinfectants should 
be subjected to worse case scenarios, such as the presence of organic or inorganic 
contamination, and under simulated use conditions.
In Europe, the CEN/TC 216 technical committee produces current and future 
disinfectant testing standards [61]. Standard EN-14885-2006 indicates test methods 
to be used to substantiate claims for products intended for instrument disinfection 
[62], including mycobacterial/tuberculocidal (EN-14348, EN 14563), bactericidal 
(EN-13727, EN-14561) and fungicidal (EN-13624, EN-14562) activity tests but the 
terms “sterility, sterile, sterilization, sterilant” fall outside the scope of CEN/TC 216.
In the US, high, intermediate and low level disinfectants, are regulated 
by the Environment Protection Agency (except HLD intended to reprocess 
medical instruments, which fall under FDA’s jurisdiction). Intermediate level 
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disinfectants must be tuberculocidal. Products effective only against vegetative 
bacteria and viruses are regarded as low level disinfectants [63].
Special testing procedures may be applicable to some pathogens of epidemio-
logical interest, such as Clostridium difficile [64]. Disinfectants are intended for use 
on inanimate surfaces. In general, their high concentration precludes their use on 
living tissues.
4.1.2 Antiseptics
Antiseptics are antimicrobials intended for use on skin and mucous membranes. 
The same as with low level disinfectants, antiseptics are tested against Escherichia 
coli, Staphylococcus aureus and Pseudomonas aeruginosa in vegetative form. In the US, 
antiseptics are regulated by the FDA.
4.2 Antimicrobial activity tests
A relevant test microorganism is chosen: preferably a strain from the American 
Type Culture Collection (ATCC) or a similar repository. Although, wild-type 
bacteria from clinical samples also have been used. All necessary controls must be 
included to assess test reliability and reproducibility. Also, it is important to differ-
entiate between kill and inhibition of growth.
The antimicrobial capability of nanoparticles has been explored by this tech-
niques due studies have suggested that NPs are excellent microbicidal activity [16, 65]. 
The in vitro tests described below are the ones that the most have been used and the 
regulatory agencies recommend to determine antimicrobial activity of chemical 
formulations and can be used in the studies of nano-antimicrobials. The use of such 
tests depends on the objectives and the type of information it want to obtain.
A first approach if nanoparticle has antimicrobial activity is to conduct an 
antimicrobial activity test, such as a disc diffusion test.
4.2.1 Disk-diffusion method
Mueller-Hinton agar (pH 7.2–7.4) is the culture medium of choice. To standard-
ize disc diffusion, the agar is poured into either Petri dish to only 4 mm in depth, as 
indicated in the Clinical and Laboratory Standards Institute method [66].
The bacteria are suspended to a 0.5 McFarland turbidity standard equivalent to 
150 × 106 cfu/mL. From this suspension, 100 μL are uniformly spread onto the agar. 
Filter-paper discs 6 mm diameter, containing the test nano-antimicrobial, will be 
placed over the seeded agar (alternatively, a 50–100 μL well, punched into the agar, 
will contain the test antimicrobial). After overnight incubation at 37°C, the plates 
will be examined to assess inhibition rings around the disc.
The size of the nanoparticle, its rate of diffusion, the agar’s porosity, and pos-
sible charge interactions between the antimicrobial and the agar may affect diffu-
sion and the final size of the inhibition zone. In theory, the highest concentrations 
will be near the antimicrobial-containing disc and will be diluted away from the 
center (Figure 2).
4.2.2 Agar dilution method
This method is the gold standard for assessing the minimal inhibitory concen-
tration (MIC) [67]. In this method, the melted agar is mixed to contain serial dilu-
tions of the nano-antimicrobial. The resulting antimicrobial containing medium 
is plated into Petri dishes. An aliquot containing 104 cfu of the test microorganism 
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is placed onto the agar’s surface, and incubated overnight. Then, the plates will be 
examined for growth to determine the last effective concentration to inhibit growth 
(Figure 3).
4.2.3 Broth dilution method
This method is often used because is more versatile and less laborious than the 
agar dilution method. Its microtiter plate version (broth microdilution), allows for 
testing more microorganisms against diverse concentrations of nano-antimicrobials, 
and can be automated.
Test tubes or wells in a microtiter plate, are prepared with bacteriological 
broth containing serial dilutions of the test nano-antimicrobial, and seeded with 
Figure 2. 
Disk-diffusion method with NPs.
Figure 3. 
Agar dilution method with NPs.
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bacteria. After, overnight incubation, the tubes or wells are inspected for growth. 
The lowest concentration of nanoparticles that results in no-growth is the MIC 
[68] (Figure 4).
4.2.4 Time-kill method
After adding the test formulation to a broth culture, antimicrobial activ-
ity can be assessed in vitro by collecting sequential samples to count survivors. 
Time-kill allows the assessment of in-vitro synergy or antagonism between 
nano-antimicrobials.
For the time-kill experiments, Mueller Hinton broth is prepared with serial 
dilutions of the test antimicrobial, alone or in combination. The nano-antimicrobial 
concentrations may span a range above and below the formulation’s MIC, previously 
obtained from agar dilution tests. Broths are then inoculated with 106 cfu/mL and 
incubated overnight at 37°C. From time 0 when bacteria are first exposed to the test 
antimicrobial, samples are obtained at 30 min intervals for up to 6 h. The samples 
are then plated on nutrient agar. After incubation overnight at 37°C, survivor counts 
are plotted to obtain a ‘time-kill curve’ [69].
5. Conclusions
Taking into account the future development and applications of the metal oxides 
nanoparticles in medicine, a constant search as emergent antimicrobial agents is 
required, due to the increase of diseases caused by microorganisms resistant to the 
action of antimicrobial agents as antibiotics.
Implementation of the metal oxides nanoparticles as an alternative to combat 
bacterial resistance due to increased findings in the mechanisms by which they 
act, have been the key to a better understanding and approach about the effect and 
kinetics that metal oxides nanoparticles have on microbial strains.
For this reason it is necessary to establish guidelines and quality standards 
to research nano-antimicrobials given the fact that there are many alternative 
methods in vitro testing to achieve this objective, but some of them present 
Figure 4. 
Broth dilution method with NPs.
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limitations, while searching for new methods could be able to present specific 
results that allow us to compare them with in vivo testing.
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